Schrödinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced that members of the management team will participate in a fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference at 12:30 p.m. ET on Tuesday, September 15, 2020.
A live webcast of the presentation can be accessed under "News & Events" in the investors section of Schrödinger’s website https://ir.schrodinger.com/news-and-events/event-calendar. A replay of the webcast will be available on Schrödinger’s website for 90 days following the event.
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.
Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 400 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com. Follow us on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005137/en/
View this news release online at: